Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

New Pharmaceutical Regulations In 2008

This article was originally published in PharmAsia News

Executive Summary

New Pharmaceutical Regulations In 2008 Whether China's pharmaceutical industry will continue making gains depends on 2008's health reform plan and new regulations taking effect Jan. 1, such as those for drug GMP authentication standards and pollutant standards. Also coming into effect in the new year are laws for anti-monopoly and new corporate income taxes. Analysts see the revised taxation law, which standardizes tax rates at 25 percent for domestic and foreign-funded companies, as a significant milestone for local enterprises as they will be more competitive with multinational corporations. (Click here for more)
Advertisement
Advertisement
UsernamePublicRestriction

Register

SC066787

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel